Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · IEX Real-Time Price · USD
6.28
+0.33 (5.55%)
Feb 6, 2023, 10:56 AM EST - Market open
Income Statement (Annual)
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Selling, General & Admin
|
2.3 | 0.9 | 0.92 |
| Research & Development
|
3.39 | 4.69 | 3.7 |
| Operating Expenses
|
5.69 | 5.59 | 4.62 |
| Operating Income
|
-5.69 | -5.59 | -4.62 |
| Interest Expense / Income
|
0.01 | 0.01 | 0.01 |
| Other Expense / Income
|
-0.17 | -0.01 | -0.04 |
| Pretax Income
|
-5.53 | -5.59 | -4.6 |
| Net Income
|
-5.53 | -5.59 | -4.6 |
| Shares Outstanding (Basic)
|
15 | 18 | - |
| Shares Outstanding (Diluted)
|
15 | - | - |
| Shares Change
|
-14.34% | - | - |
| EPS (Basic)
|
-0.37 | - | - |
| EPS (Diluted)
|
-0.37 | - | - |
| Free Cash Flow Per Share
|
-0.46 | -0.34 | - |
| EBITDA
|
-5.51 | -5.58 | -4.59 |
| Depreciation & Amortization
|
0 | 0 | 0 |
| EBIT
|
-5.52 | -5.58 | -4.59 |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).